Search
RESPOND Study Group

The International Multicohort Consortium of Infectious Disease study group

AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA): ​F Wit, P Reiss, M Hillebregt, Stichting HIV Monitoring (SHM), Amsterdam, Netherlands

The Australian HIV Observational Database (AHOD): M Law, K Petoumenas, R Puhr, UNSW, Sydney, Austalia 

Austrian HIV Cohort Study (AHIVCOS): R Zangerle, H Appoyer, Medizinische Universität Innsbruck, Innsbruch, Austria

CHU Saint-Pierre, S De Wit, M Delforge, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium

EuroSIDA Cohort: J Rockstroh, CHIP, Rigshospitalet, RegionH, Copenhagen, Denmark

Frankfurt HIV Cohort Study: C Stephan, M Bucht, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany

Georgian National AIDS Health Information System (AIDS HIS): N Chkhartishvili, O Chokoshvili,  Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia

Italian Cohort Naive Antiretrovirals (ICONA): A d’Arminio Monforte, A Rodano, A Tavelli,  ASST Santi Paolo e Carlo, Milan, Italy; I Fanti, Icona Foundation, Milan, Italy.

Modena HIV Cohort: C Mussini, V Borghi, Università degli Studi di Modena, Modena, Italy

Nice HIV Cohort: C Pradier, E Fontas, K Dollet, C Caissotti, Université Côte d’Azur et Centre Hospitalier Universitaire, Nice, France.

PISCIS Cohort Study: J Casabona, JM Miro, Centre Estudis Epidemiologics de ITS i VIH de Catalunya (CEEISCAT), Badalona, Spain

Royal Free Hospital Cohort: C Smith, F Lampe, Royal Free Hospital, University College London, London, United Kingdom

San Raffaele Scientific Institute​: ​A Castagna, A Lazzarin, A Poli, Università Vita-Salute San Raffaele, Milano, Italy

Swedish InfCare HIV Cohort: A Sönnerborg, K Falconer, V Svedhem, Karolinska University Hospital, Stockholm, Sweden

Swiss HIV Cohort Study (SHCS): H Günthard, B Ledergerber, H Bucher, A Scherrer, University of Zurich, Zurich, Switzerland

University Hospital Bonn: JC Wasmuth, J Rockstroh, Bonn, Germany

University Hospital Cologne: JJ Vehreschild, G. Fätkenheuer, Cologne, Germany


RESPOND Executive Committee 
A Mocroft*, G Reilly, J Rooney, V Vannappagari, H Garges, J Rockstroh, M Law, C Smith, S De Wit, J Lundgren, H Günthard
*Chair


RESPOND Scientific Steering Committee
J Lundgren*, H Günthard*, J Kowalska, D Raben, L Ryom, A Mocroft, J Rockstroh, L Peters, A Volny Anne, N Dedes, N Chkhartishvili, R Zangerle, M Law, F Wit, C Necsoi, C Stephan, C Pradier, A D’Arminio Monforte, C Mussini, A Bruguera, H Bucher, A Sönnerborg, JJ Vehreschild, C Smith, A Castagna, G Reilly, J Rooney, V Vannappagari, H Garges
*Chairs


RESPOND Staff
Coordinating Centre Staff: D Raben, L Peters, L Ryom, B Neesgaard, JF Larsen, ML Jakobsen, T Bruun, A Bojesen, P Iversen, EV Hansen, TW Elsing, A Mocroft, L Greenberg
 

Funding

The International Cohort Consortium of Infectious Disease (RESPOND) has received funding from ViiV Healthcare LLC and Gilead Sciences. Additional support has been provided by participating cohorts contributing data in-kind and/or statistical support: Austrian HIV Cohort Study (AHIVCOS), The Australian HIV Observational Database (AHOD), CHU Saint-Pierre, University Hospital Cologne, The EuroSIDA cohort, Frankfurt HIV Cohort Study, Georgian National AIDS Health Information System (AIDS HIS), Modena HIV Cohort, San Raffaele Scientific Institute, Swiss HIV Cohort Study (SHCS), Royal Free HIV Cohort Study.